ACRO 2012: Register by Friday, save $100
Register today for the ACRO 2012 Annual Meeting, Feb. 23-25 at the Sanibel Harbour Marriott in Fort Myers, Fla. The ACRO Annual Meeting is known for its fundamental, clinically focused program and faculty, intimate nature, unparalleled access to speakers, clutter-free schedule and a full slate of CME and SAM credit. As an added bonus, the college is discounting meeting registrations up to $100 on all completed registrations, online or faxed in, received on or before Jan. 20. Click here to register today.
ACRO Audio Brief
Over the next few weeks, ACRO will be promoting audio briefs of popular and insightful content from past annual meetings. This week's audio brief features a presentation titled "Clinical Outcomes and Toxicity Using Stereotactic Radiotherapy (SBRT) for Non-Liver Abdominal Cavity Tumors" by Dr. Brandon Barney from the Mayo Clinic. Click here to listen to the brief.
After urologists got machine, cancer treatments soared
The Baltimore Sun Share
Four years ago, doctors at Chesapeake Urology Associates started ordering the most expensive kind of prostate cancer therapy for many more of their patients. Before 2007, the large, multi-office practice was prescribing the treatment, known as intensity modulated radiation therapy, for 12 percent of its prostate cancer patients covered by Medicare, according to data compiled by a Georgetown University researcher. But starting in mid-2007, Chesapeake Urology's referral rate for IMRT more than tripled, rising to 43 percent of the Medicare cases. What could have caused such a sharp change? More
Genetic mutation shown in some men with prostate cancer
The Baltimore Sun via Sacramento Bee Share
Researchers at Johns Hopkins and the University of Michigan have discovered an inherited mutation linked to significantly higher risk of prostate cancer development at a younger age. The discovery, after two decades of looking, provides insight into the disease development. And though those with the mutation comprise just a fraction of the 240,000 new cases diagnosed annually, the discovery could also help doctors determine who needs earlier screening. More
EHRs, genomics power personalized cancer treatments
Computer maker Dell is counting on the cloud, analytics, and "big data" to power the future of medicine and make healthcare more personal. The Texas-based hardware giant is putting the infrastructure in place to support electronic health records and genomics on the journey from episodic care to coordinated care to personalized medicine. "You can't do personalized medicine without EHRs and genomic sequencing," Jamie Coffin, vice president and general manager of Dell Healthcare and Life Sciences, told InformationWeek Healthcare. More
Diagnostic radiation threats: The debate continues
Some experts say fears of radiation exposure in the healthcare setting are overblown — even sensationalized, according to an article on Medicalxpress.com, which lays out both sides of the long-running debate over medical radiation safety. Diagnostic imaging procedures should be conducted at the lowest radiation dose to make a diagnosis, the American Association of Physicists in Medicine said in a statement. But clinicians should discuss both radiation risks and benefits of procedures with patients, according to the statement. More
Bladder cancer: Differentiate between types when conducting studies
Medical News Today Share
According to a detailed trends examination, there are considerable differences between the main subtypes of bladder cancer. Due to this, investigators are being asked to make a distinction between both types of the disease when they conduct studies. In the January edition of the urology journal BJUI, a large investigation of almost 128,000 cases of bladder cancer in the U.S. revealed that the disease showed a 9 percent overall decrease between 1973 and 2007. More
Is My Radiation Oncology Practice Prepared for 2012?
ACRO webinar | Thursday, Jan. 26
4 p.m. EST
Join Ron DiGiaimo as he discusses and summarizes the key areas within the Final Rule that may affect your Radiation Oncology practice. Ron will focus on implementing the necessary changes to current work flows to ensure documentation and billing processes are in compliance with payer requirements while ensuring potential revenues are not lost. The importance of annual fee schedule reviews, staff education as well as a teamwork approach between physicians and clinical staff will be included. This is a free webinar for all ACRO members. Register now by logging into the members-only section of acro.org. Contact email@example.com with any questions.
Researchers: Women 'over-diagnosed' with breast cancer
NewsCore via Fox News Share
Women are being treated unnecessarily for breast cancer due to mammograms "over-diagnosing" cancers, which never would cause harm, according to an Australian report. In an article published in the Medical Journal of Australia, Monash University breast cancer researchers Robin Bell and Robert Burton called for women invited to use the country's publicly funded BreastScreen program to be presented with a more balanced view about the benefits and harms of breast screening. More
The colon cancer screening controversy: How old is too old to screen?
Becker's ASC Review Share
A recent study in the Archives of Internal Medicine found 57 percent of seniors ages 75-79 had been screened for colon cancer despite the increased risks and limited benefit. The study was followed by calls to set upper age limits for colon cancer screening. However, Andrew Spiegel, CEO of the Colon Cancer Alliance, says older patients still should be screened for colon cancer because the average age at diagnosis is 71, and 43 percent of cases are diagnosed at age 75 and older. More
IGF-I doesn't predict late complications in childhood cancer survivors
Family Practice News Share
Insulinlike growth factor I level was not useful as a marker of growth hormone deficiency or altered body composition in a retrospective review of a large cohort of adult survivors of childhood cancers. Late cancer treatment–related complications — metabolic syndrome, osteogenic side effects, thyroid dysfunction, and growth hormone deficiency — are increasing as a result of increased childhood cancer survivorship; 1 in 640 young adults is now a survivor of childhood cancer, she said. More
China cancer village tests law against pollution
Nothing in Wu Wenyong's rural childhood hinted he would end up on a hospital bed aged 15, battling two kinds of cancer. Born to poor farmers in Xiaoxin, a dusty village of low brick houses in southwestern Yunnan province, he paddled in the Nanpan River as a child and later helped his parents tend rice. About 3 kilometers (2 miles) from Wu's home stands a three-storey high hill of chromium slag produced from the Yunnan Luliang Peace Technology Company. The runoff from chromium-6, listed as a carcinogen by the World Health Organization, seeped into the Nanpan, turning its waters yellow. More